It's Friday, so it's time to bring you another run-down of the top ten most popular articles with Pharmafile.com's readers this week.
Despite a drought of mergers and acquisitions throughout 2017, rumours are already circulating on what deals may occur this year, and among them, Celgene is expected to attempt to acquire Juno Therapeutics and the valuable CAR T therapy it is developing for $7 billion.
